GL1X · GenesisL1 explorer

MolNFT v1 · #38383 · protein

Crystal structure of human nmprtase in complex with FK866

2GVJ · Nicotinamide phosphoribosyltransferase: “Crystal structure of human nmprtase in complex with FK866”. X-ray diffraction, 1 ligand (DGB), 8 pockets (best druggability 0.80). MolNFT v1 #38383 on GenesisL1: 3D structure, binding sites…

PDB
2GVJ
Type
protein
Length
929 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nicotinamide phosphoribosyltransferase
EC
2.4.2.12
UniProt
P43490
Ligands
DGB
Pockets
8 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANicotinamide phosphoribosyltransferase (EC 2.4.2.12)protein46541% helix, 19% strandP43490
BNicotinamide phosphoribosyltransferase (EC 2.4.2.12)protein46441% helix, 19% strandP43490

Ligands and binding sites

  • DGB · (2E)-N-{4-[1-(benzenecarbonyl)piperidin-4-yl]butyl}-3-(pyridin-3-yl)prop-2-enamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17150.800.8478DGB
27490.790.8386DGB
35310.690.7849empty
4500.320.7816empty
5670.320.7516empty

Interfaces

1 interface between chains.

  • A–B · 4319 Ų buried · 78 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (engineered).

Compared structures

  • 2GVJ · Crystal Structure of Human NMPRTase in complex with FK866 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.